This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02954/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02954/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02954/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02954/identifier/pdb/

Statements

Subject Item
n2:DB02954
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB02954 n10:DB02954
dcterms:title
(Carboxyhydroxyamino)Ethanoic Acid
adms:identifier
n4:46505870 n11:HAD n12:4633094 n13:DB02954
n5:IUPAC-Name
n6:271B416F-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4175-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4174-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4171-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4172-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4173-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B416D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B416B-363D-11E5-9242-09173F13E4C5 n6:271B416E-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B416C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B417B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B417C-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4176-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4177-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4179-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4178-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B417A-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4181-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4183-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4184-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4180-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B417F-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4182-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4170-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B417D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B417E-363D-11E5-9242-09173F13E4C5